Precision medicine in the acute care of stroke has undergone significant advancements, particularly since 2015, when five ...

BASEL, Switzerland—Multiple randomized trials presented last week at the European Stroke Organisation Conference (ESOC) 2024 have bolstered the case that tenecteplase (TNK) is an effective—if not ...

Please provide your email address to receive an email when new articles are posted on . Recent FDA actions include approval of the first new treatment for acute stroke in 30 years. FDA also cleared a ...

The American Academy of Neurology (AAN) has issued a new position statement on "Consent Issues in the Management of Acute Ischemic Stroke," the first update in more than 20 years. The statement was ...

Study in Lancet Digital Health represents the largest real-world evaluation of stroke AI imaging, encompassing data from more ...

With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important ...

Cheonan Hospital (Hospital Director Lee Moon-soo) affiliated with Soonchunhyang University announced on the 17th that it has ...

The US Food and Drug Administration has approved the thrombolytic tenecteplase for the treatment of patients with acute ischemic stroke, manufacturer Genentech announced today. The approval is based ...

In 2006, Kevin Sheth was a 27-year-old neurology resident in Boston, at both Massachusetts General Hospital and Brigham and Women’s Hospital. In that role, he did rotations within their neurology ...

The removal of a hyper-acute stroke unit at a hospital will begin in the spring, health bosses have announced. It means that, ...